Anti-CRF antibody-mediated HPA axis modulation induces selective fat mass loss with lean mass preservation

The hypothalamic-pituitary-adrenal (HPA) axis integrates central neural processing and responses to stress with endocrine and metabolic responses. We utilized a monoclonal antibody binding corticotrophin-releasing factor (anti-CRF) to achieve durable HPA axis modulation. In mice, anti-CRF treatment decreased plasma corticosterone, food-intake, body weight and fat mass, but preserved lean mass and improved metabolic parameters including insulin sensitization. These body composition effects were observed in middle aged mice on normal chow or high fat diet, aged mice, and Mc4r -/- and ob/ob mice. Single-dose studies demonstrated impacts on weight gain and body composition lasting beyond the period of pharmacological target engagement. Multi-organ transcriptomic and proteomic analyses revealed organ-specific effects of anti-CRF and are consistent with altered glucocorticoid receptor (GR) signaling as a mediator of the observed phenotypes. These studies support anti-CRF-mediated HPA-axis modulation as a metabolic and anti-obesity therapeutic approach distinct from incretins.

Authors

Institutions

Publication Details

Journal
JCI Insight
Published
2026-10-06
DOI
https://doi.org/10.1172/jci.insight.210525
Primary Topic
Regulation of Appetite and Obesity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-CRF antibody-mediated HPA axis modulation induces selective fat mass loss with lean mass preservation

Jada M. Lewis, Karen A. Scott, Tariful Islam, Jennifer L. Bizon et al.
JCI Insight
Regulation of Appetite and Obesity
article

Anti-CRF antibody-mediated HPA axis modulation induces selective fat mass loss with lean mass preservation

Jada M. Lewis, Karen A. Scott, Tariful Islam, Jennifer L. Bizon, Yona Levites, Hunter S. Futch, Thomas B. Ladd, Zachary A. Krumm, Nicholas T. Seyfried, Caroline M Watson, Karen N. McFarland, Annette D. de Kloet, Danny Ryu, Eric G. Krause, Kazi Farhana Afroz, Todd Eliot Golde, Kristy D. Dillon, Edgardo Rodríguez-Lebrón, Yong Ran, Xuefei Liu, Luming Yin, Ariella Goloborodsky
article en

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis integrates central neural processing and responses to stress with endocrine and metabolic responses. We utilized a monoclonal antibody binding corticotrophin-releasing factor (anti-CRF) to achieve durable HPA axis modulation. In mice, anti-CRF treatment decreased plasma corticosterone, food-intake, body weight and fat mass, but preserved lean mass and improved metabolic parameters including insulin sensitization. These body composition effects were observed in middle aged mice on normal chow or high fat diet, aged mice, and Mc4r -/- and ob/ob mice. Single-dose studies demonstrated impacts on weight gain and body composition lasting beyond the period of pharmacological target engagement. Multi-organ transcriptomic and proteomic analyses revealed organ-specific effects of anti-CRF and are consistent with altered glucocorticoid receptor (GR) signaling as a mediator of the observed phenotypes. These studies support anti-CRF-mediated HPA-axis modulation as a metabolic and anti-obesity therapeutic approach distinct from incretins.

JCI Insight
Emory University (US), Georgia State University (US), German Center for Neurodegenerative Diseases (DE), McKnight Brain Research Foundation (US), Institute for Neurodegenerative Disorders (US), Department of Physiological Sciences (RU)
Openalex Percentile: Top 16%
Regulation of Appetite and Obesity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.